Raspberryketone
CAS 5471-51-2
Raspberryketone (CAS 5471-51-2) is a pharmaceutical compound with 1 bioactivity target and 16 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 100000 nM | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| 4-(P-Hydroxyphenyl)-2-Butanone | 1860422 | SU | MTHSPL |
| 4-(P-HYDROXYPHENYL)-2-BUTANONE | 1860422 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Raspberryketone used for in pharmaceutical contexts?
Raspberryketone (CAS 5471-51-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Raspberryketone?
Raspberryketone has 16 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Bronchitis, Cough, Nerve compression, Pneumonia, Prostatitis. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Raspberryketone also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Raspberry Ketone with EU status "permitted".
What clinical phase is Raspberryketone in?
No phase 1-4 clinical development badge is rendered for Raspberryketone because the matched compound identifier rows do not contain a max-phase value.